Australia - English - Department of Health (Therapeutic Goods Administration)

sandoz pty ltd - teicoplanin, quantity: 400 mg - injection, powder for - excipient ingredients: sodium chloride - teicoplanin sandoz is indicated for the treatment of the following serious infections due to staphylococci or streptococci, which cannot be treated satisfactorily with less toxic agents, including beta-lactam antibiotics: bone (osteomyelitis); joints (septic arthritis); blood (non-cardiac bacteraemia, septicaemia).

Australia - English - Department of Health (Therapeutic Goods Administration)

southern cross pharma pty ltd - teicoplanin, quantity: 400 mg - injection, powder for - excipient ingredients: sodium hydroxide; sodium chloride - teicoplanin is indicated for the treatment of the following serious infections due to staphylococci or streptococci, which cannot be treated satisfactorily with less toxic agents, including beta-lactam antibiotics: bone (osteomyelitis); joints (septic arthritis); blood (noncardiac bacteraemia, septicaemia).

New Zealand - English - Medsafe (Medicines Safety Authority)

viatris limited - teicoplanin 400mg - powder for injection - 400 mg - active: teicoplanin 400mg excipient: sodium chloride sodium hydroxide - teicoplanin mylan is indicated in adults and in children from 2 months for the treatment of the following serious infections due to staphylococci or streptococci, which cannot be treated satisfactorily with less toxic agents including beta-lactam antibiotics: bone - osteomyelitis

Australia - English - Department of Health (Therapeutic Goods Administration)

medsurge pharma pty ltd - teicoplanin, quantity: 400 mg - injection, diluent for - excipient ingredients: water for injections - teicoplanin is indicated for the treatment of the following infections due to staphylococci or streptococci, which cannot be treated satisfactorily with less toxic agents, including b-lactam antibiotics: - bone - osteomyelitis; joints - septic arthritis; blood - non-cardiac bacteraemia, septicaemia.

Australia - English - Department of Health (Therapeutic Goods Administration)

medsurge pharma pty ltd - teicoplanin, quantity: 400 mg - injection, powder for - excipient ingredients: sodium chloride; sodium hydroxide - teicoplanin is indicated for the treatment of the following infections due to staphylococci or streptococci, which cannot be treated satisfactorily with less toxic agents, including b-lactam antibiotics: - bone - osteomyelitis; joints - septic arthritis; blood - non-cardiac bacteraemia, septicaemia.

Australia - English - Department of Health (Therapeutic Goods Administration)

sanofi-aventis australia pty ltd - teicoplanin, quantity: 400 mg - injection, powder for - excipient ingredients: sodium chloride - targocid is indicated for the treatment of the following infections due to staphylococci or streptococci, which cannot be treated satisfactorily with less toxic agents, including b-lactam antibiotics: - bone - osteomyelitis; joints - septic arthritis; blood - non-cardiac bacteraemia, septicaemia.

Ireland - English - HPRA (Health Products Regulatory Authority)

generics (uk) limited - teicoplanin - pdr for soln inj/inf - 100 milligram - teicoplanin

Ireland - English - HPRA (Health Products Regulatory Authority)

generics (uk) limited - teicoplanin - pdr for soln inj/inf - 200 milligram - teicoplanin

Ireland - English - HPRA (Health Products Regulatory Authority)

generics (uk) limited - teicoplanin - pdr for soln inj/inf - 400 milligram - teicoplanin

Malta - English - Medicines Authority

ibigen s.r.l via fossignano, 2, 04011 aprilia (lt), italy - teicoplanin - powder and solvent for solution for infusion or injection oral solution - teicoplanin 200 mg - antibacterials for systemic use